Acumen Pharmaceuticals, Inc.ABOSNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-86.23M
↓ 163% below average
Average (5y)
$-32.82M
Historical baseline
Range
High:$-6.82M
Low:$-86.23M
CAGR
+66.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-86.23M | -100.1% |
| 2023 | $-43.09M | -22.0% |
| 2022 | $-35.31M | -96.2% |
| 2021 | $-18.00M | -141.6% |
| 2020 | $-7.45M | -9.3% |
| 2019 | $-6.82M | - |